« Back
Home /
Vipivotide tetraxetan (PSMA-617)

Vipivotide tetraxetan (PSMA-617)

Item no.	S8670-25mg
Manufacturer	Selleckchem
CASRN	1702967-37-0
Amount	25 mg
Quantity options	1 mg 100 mg 2 mg 25 mg 5 mg
Category	Oncology By Cell Type Blastoma Carcinoma Inhibitors & Compound Libraries Small Molecules By Organ Testicular & Prostate Cancer
Type	Inhibitors
Specific against	other
Smiles	C1CC(CCC1CNC(=O)CN2CCN(CCN(CCN(CC2)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)NC(CC3=CC4=CC=CC=C4C=C3)C(=O)NCCCCC(C(=O)O)NC(=O)NC(CCC(=O)O)C(=O)O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Storage Conditions	3 years -20°C powder
Information	Vipivotide tetraxetan (PSMA-617) is a chemically modified PSMA(prostate-specific membrane antigen) inhibitor with a Ki of 0.37 nM.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

S8670-25mg-datasheet.pdf

S8670-25mg-safety-datasheet.pdf